Bio-Rad Laboratories | BIO - Eigenkapital Und Reserven

Aktienkurs
280.12
Täglich Wechseln
4.97 1.81%
Monatlich
0.49%
Jährlich
16.75%
Q2 Prognose
281.68




Eigenkapital Und Reserven Veränderung Datum
Abbott USD 52.06B 69M 2026-03
Agilent USD 6.91B 167M 2025-12
Becton, Dickinson and Co. USD 25.28B 108M 2025-12
Bio Techne USD 2.01B 45.18M 2025-12
Bio-Rad Laboratories USD 6.85B 602.3M 2026-03
Bruker USD 2.49B 625.6M 2025-09
Charles River Laboratories USD 3.16B 240.82M 2025-12
Danaher USD 52.95B 415M 2026-03
General Electric Aerospace USD 18.06B 841M 2026-03
Illumina USD 2.72B 342M 2025-12
IQVIA Holdings USD 6.5B 343M 2025-12
Laboratory Of America USD 8.62B 93.2M 2025-12
Merck USD 52.61B 756M 2025-12
Mettler Toledo International USD -23.64M 225.56M 2025-12
Myriad Genetics USD 368M 4.8M 2025-12
OraSure Technologies USD 340.83M 21.15M 2025-12
Pacific Biosciences Of California USD 5.35M 30.74M 2025-12
Quest Diagnostics USD 7.37B 196M 2026-03
Repligen USD 2.11B 1.66B 2025-12
Revvity USD 7.38B 180.27M 2025-09
Roche Holding CHF 33.8B 758M 2025-12
Siemens EUR 65.48B 3.24B 2025-12
Standard Biotools USD 424.29M 24.63M 2025-12
Thermo Fisher Scientific USD 53.54B 2.38B 2025-12
Tosoh JPY 803.3B 7.06B 2025-12
Waters USD 2.56B 230.55M 2025-12